1. Pollack A. Hepatitis C, a silent killer, meets its match. New York Times, Nov. 4, 2013.
2. Targeted drugs to tackle hepatitis C;Mole;Nature,2013
3. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890;Hezode;J Hepatol,2013
4. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir;Bichoupan;Aliment Pharmacol Ther,2013
5. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989